Revelation Biosciences, Inc. (REVBW) Ownership

$0.01

$0 (11.54%)
Last update: 04:00 PM EST
Day's range
$0.01
Day's range
$0.01

Revelation Biosciences, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
LINDEN ADVISORS LP 05/15/2025 338.11 K $3.70 K   0.00% 34.81%
YAKIRA CAPITAL MANAGEMENT, INC. 05/14/2025 246.88 K $2.68 K   0.00% 25.42%
TABOR ASSET MANAGEMENT, LP 05/05/2025 246.88 K $2.68 K   100.00% 25.42%
WOLVERINE ASSET MANAGEMENT LLC 05/12/2025 54.75 K $591   0.00% 5.64%
JANE STREET GROUP, LLC 05/19/2025 50.00 K $540   0.00% 5.15%
CITADEL ADVISORS LLC 05/15/2025 36.57 K $366   -4.36% 3.76%
POM INVESTMENT STRATEGIES, LLC 04/30/2025 1.01 K $11   0.00% 0.10%
QUAKER WEALTH MANAGEMENT, LLC 05/29/2025 387 $5   100.00% 0.04%
UBS GROUP AG 05/13/2025 272 $3   -89.17% 0.03%
WALLEYE TRADING LLC 05/14/2025 0 $0   -100.00% 0.00%
TWO SIGMA SECURITIES, LLC 05/15/2025 0 $0   -100.00% 0.00%
WALLEYE CAPITAL LLC 05/14/2025 0 $0   -100.00% 0.00%

Revelation Biosciences, Inc. institutional Ownership - FAQ's

During the previous two years, 16 institutional investors and hedge funds held shares of Revelation Biosciences, Inc.. The most heavily invested institutionals were:

LINDEN ADVISORS LP: 338,110

Tabor Asset Management, LP: 246,884

Yakira Capital Management, Inc.: 246,884

WOLVERINE ASSET MANAGEMENT LLC: 54,752

JANE STREET GROUP, LLC: 50,000

CITADEL ADVISORS LLC: 36,568

100.33% of Revelation Biosciences, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 1.63 M shares in the last 24 months. This purchase volume represents approximately $16.25 K in transactions.